Abstract:Background/objective: Approximately one-third of pregnant individuals in the U.S. are affected by obesity, which can adversely impact the in utero environment and offspring. This study aimed to investigate the differences in urine metabolomics between children exposed and unexposed to maternal obesity. Methods: In a study nested within a larger pregnancy cohort of women–offspring pairs, we measured untargeted metabolomics using liquid chromatography–mass spectrometry in urine samples from 68 children at 4–8 years of age. We compared metabolite levels between offspring exposed to maternal obesity (body mass index [BMI] ≥ 30.0 kg/m2) vs. unexposed (maternal BMI 18.5–24.9 kg/m2) and matched them on covariates, using two-sample t-tests, with additional sensitivity analyses based on children's BMI. This study reports statistically significant results (p ≤ 0.05) and potentially noteworthy findings (fold change > 1 or 0.05 < p < 0.15), considering compounds' involvement in common pathways or similar biochemical families. Results: The mean (SD) maternal age at study enrollment was 28.0 (6.3) years, the mean child age was 6.6 (0.8) years, 56% of children were male, and 38% of children had a BMI in the overweight/obese range (BMI ≥ 85th percentile). Children exposed to maternal obesity had lower levels of 5-hydroxyindole sulfate and 7-hydroxyindole sulfate and higher levels of secondary bile acids. Phenylacetic acid derivatives were lower in offspring exposed to obesity and in offspring who had a current BMI in the overweight/obese range. Exposure to maternal obesity was associated with lower levels of androgenic steroid dehydroepiandrosterone sulfate (DHEA-S). Conclusions: In this preliminary study, children exposed to maternal obesity in utero had differences in microbiome-related metabolites in urine suggestive of altered microbial catabolism of tryptophan and acetylated peptides. Some of these differences were partially attributable to the offspring's current BMI status. This study highlights the potential of urine metabolomics to identify biomarkers and pathways impacted by in utero exposure to maternal obesity.

Metabolic maturation in the infant urine during the first 3 months of life

The Urinary Metabolome of Newborns with Perinatal Complications

Variations of Amino Acid, Free Carnitine and Acylarnitine Profiles Analysed by Tandem Mass Spectrometry in Newborns During Their First Four Weeks of Life

Comparison of Hepatic Metabolite Profiles between Infant and Adult Male Mice Using 1H-NMR-Based Untargeted Metabolomics

Urinary Metabolomic Differentiation of Infants Fed on Human Breastmilk and Formulated Milk

The Human Meconium Metabolome and Its Evolution during the First Days of Life

Biochemical Profiling of Urine Metabolome in Premature Infants Based on LC−MS Considering Maternal Influence

Practical and Robust NMR-Based Metabolic Phenotyping of Gut Health in Early Life

Metabolic Products in Urine of Preterm Infants Characterized Via Gas Chromatography-Mass Spectrometry.

Investigation of newborn blood metabolomics in varying intrauterine growth conditions

Characterization of LC-MS based urine metabolomics in healthy children and adults

The components of arginine and methylarginine metabolism are indicative of altered kidney function in intrauterine growth-restricted neonates

Gestational Dating by Urine Metabolic Profile at High Resolution Weekly Sampling Timepoints: Discovery and Validation

Characterization of LC-MS Based Urine Metabolomics in Healthy Subjects Across the Life Span

Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of Metabolism.

Individual Variability in Human Urinary Metabolites Identifies Age‐related, Body Mass Index‐related, and Sex‐related Biomarkers

Maturation of the gut metabolome during the first year of life in humans

Urinary Concentration of Renal Biomarkers in Healthy Term Neonates: Gender Differences in GST-pi Excretion

Maternal Obesity and Differences in Child Urine Metabolome

Urinary protein to creatinine ratio during the first month of life in very preterm infants—a prospective cohort study (PROTIPREMA)

93 PRESENCE OF DIURNAL VARIATION FOR IONIZED AND TOTAL Ca EXCRETION IN PREMATURE INFANTS